Full-length <i>Plasmodium falciparum</i> myosin A and essential light chain PfELC structures provide new anti-malarial targets.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33046215.
- Also identified by DOI 10.7554/eLife.60581 and PMC identifier 7553781.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Parasites from the genus Plasmodium are the causative agents of malaria. The mobility, infectivity, and ultimately pathogenesis of <i>Plasmodium falciparum</i> rely on a macromolecular complex, called the glideosome. At the core of the glideosome is an essential and divergent Myosin A motor (PfMyoA), a first order drug target against malaria. Here, we present the full-length structure of PfMyoA in two states of its motor cycle. We report novel interactions that are essential for motor priming and the mode of recognition of its two light chains (PfELC and MTIP) by two degenerate IQ motifs. Kinetic and motility assays using PfMyoA variants, along with molecular dynamics, demonstrate how specific priming and atypical sequence adaptations tune the motor's mechano-chemical properties. Supported by evidence for an essential role of the PfELC in malaria pathogenesis, these structures provide a blueprint for the design of future anti-malarials targeting both the glideosome motor and its regulatory elements.
Medical subject headings
- Antimalarials
- Nonmuscle Myosin Type IIA
- Plasmodium falciparum
- Protozoan Proteins